ru24.pro
News in English
Сентябрь
2024

Sanofi, Regeneron to seek approval for Dupixent in bullous pemphigoid after positive phase 3 study

0
Sanofi, Regeneron to seek approval for Dupixent in bullous pemphigoid after positive phase 3 study esagonowsky